a day ago
Ipca Laboratories Q1 results: Net profit surges 21% YoY to Rs 233.21 crore, revenue up 10.3%
Ipca Laboratories Limited posted a consolidated net profit attributable to owners of the company at Rs 233.21 crore for the quarter ended June 30, 2025, marking a 21% increase from Rs 192.24 crore in the same period last year. Sequentially, profit was sharply higher compared to Rs 67.82 crore in Q4 FY25.
Revenue from operations rose 10.33% year-on-year to Rs 2,308.85 crore, up from Rs 2,092.63 crore in Q1 FY25, supported by improved sales performance. Total income stood at Rs 2,341.51 crore against Rs 2,113.24 crore a year ago.
Total expenses increased to Rs 2,011 crore from Rs 1,822.85 crore last year, driven by higher employee costs at Rs 543.17 crore versus Rs 487.87 crore and other expenses at Rs 657.70 crore versus Rs 568.55 crore. Operating profit before exceptional items and tax came in at Rs 330.51 crore, up from Rs 290.39 crore last year.
Profit before tax rose to Rs 330.51 crore from Rs 290.39 crore in Q1 FY25. After accounting for tax expenses of Rs 95.34 crore and other adjustments, profit from continuing operations stood at Rs 232.89 crore.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
